<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04661293</url>
  </required_header>
  <id_info>
    <org_study_id>AMDC-EAP</org_study_id>
    <nct_id>NCT04661293</nct_id>
  </id_info>
  <brief_title>Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)</brief_title>
  <acronym>AMDC</acronym>
  <official_title>Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook MyoSite</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook MyoSite</source>
  <brief_summary>
    <textblock>
      This is an expanded access program (EAP) for eligible participants designed to provide access&#xD;
      to autologous muscle derived cells (AMDCs). Treating physicians may submit requests for&#xD;
      expanded access to Cook MyoSite's investigational product by email to&#xD;
      MYO-ExpandedAccess@CookMyoSite.com.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cook MyoSite, Inc. (Cook MyoSite) is committed to conducting rigorous, controlled clinical&#xD;
      trials with variable inclusion and exclusion criteria based upon the indicated use under&#xD;
      investigation. Participation in our clinical trials is the first and most preferable route to&#xD;
      access our investigational product.&#xD;
&#xD;
      We understand that there may be patients with a serious, life-threatening disease or&#xD;
      condition that have explored all other treatment options and are unable or ineligible to&#xD;
      participate in our clinical trials. Expanded access, otherwise known as &quot;compassionate use&quot;&#xD;
      or &quot;pre-approval access,&quot; is a potential pathway to access an investigational product that a&#xD;
      patient may otherwise be unable to receive.&#xD;
&#xD;
      Cook MyoSite will consider providing an investigational product to a qualified requesting&#xD;
      physician currently licensed within the United States via the United States Food and Drug&#xD;
      Administration's (FDA's) expanded access pathway outside of an active clinical trial when&#xD;
      eligibility criteria are met.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <expanded_access_info>
    <expanded_access_type_individual>Yes</expanded_access_type_individual>
  </expanded_access_info>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous Muscle Derived Cells (AMDCs)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Eligibility Criteria:&#xD;
&#xD;
          1. The patient has a serious or life-threatening disease or condition with no&#xD;
             satisfactory alternative.&#xD;
&#xD;
          2. Positive assessment that the anticipated benefits outweigh the risks to the patient.&#xD;
&#xD;
          3. Positive assessment that Cook MyoSite has an adequate supply of resources for&#xD;
             producing the investigational product.&#xD;
&#xD;
          4. A determination that expanded access will not interfere with Cook MyoSite's ability to&#xD;
             complete clinical trials in a timely fashion or which might otherwise delay marketing&#xD;
             approval and ultimately availability to all patients.&#xD;
&#xD;
          5. The patient can undergo a muscle biopsy procedure(s).&#xD;
&#xD;
          6. The patient can undergo Cook MyoSite's required donor screening and testing.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Cook MyoSite</last_name>
    <phone>412-963-7380</phone>
    <email>MYO-ExpandedAccess@CookMyoSite.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cook MyoSite, Inc.</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15238</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Available</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://resources.cookmyosite.com/terms-and-conditions-of-sale-and-delivery-0</url>
    <description>Cook MyoSite, Inc. Expanded Access Webpage</description>
  </link>
  <link>
    <url>https://www.cookmyosite.com/</url>
    <description>Cook MyoSite, Inc. Webpage</description>
  </link>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 3, 2020</study_first_submitted>
  <study_first_submitted_qc>December 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>December 9, 2020</last_update_submitted>
  <last_update_submitted_qc>December 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

